Cytarabine 100mg/ml Solution for Injection 10ml Vial

Cytarabine is a potent antineoplastic agent widely utilized in the treatment of various types of cancer. This solution for injection, containing 100 mg of Cytarabine per milliliter, is supplied in a 10ml vial, making it a critical medication in oncology protocols.

As referenced on leading pharmaceutical and e-commerce platforms like NahdiOnline, , and for similar products, Cytarabine is crucial for its role in targeting rapidly dividing cancer cells. It functions as an antimetabolite, interfering with DNA synthesis and repair, thereby inhibiting cancer cell growth.

Benefits of Use:

• Effective in treating Acute Myeloid Leukemia (AML) and Acute Lymphocytic Leukemia (ALL).
• Used in combination therapy for certain types of non-Hodgkin's Lymphoma.
• Acts by interfering with cancer cell replication, leading to cell death.

How to Use:

1. This medication must be administered only by qualified healthcare professionals experienced in administering chemotherapeutic agents.
2. The dosage, frequency, and route of administration (intravenous, subcutaneous, or intrathecal) are determined by your physician based on the specific type of cancer, patient's condition, body surface area, and treatment protocol.
3. Strict aseptic techniques must be followed during the preparation and administration of the injection to prevent contamination.
4. Patients will undergo regular monitoring of blood counts (complete blood count with differential), liver function tests, and kidney function tests throughout the treatment period.

Caution & Warnings:

• Bone Marrow Depression: Cytarabine can cause severe and life-threatening bone marrow suppression, leading to leukopenia, thrombocytopenia, and anemia.
• Neurotoxicity: High doses or intrathecal administration may lead to severe neurotoxicity, including cerebral or cerebellar dysfunction, and paralysis.
• Gastrointestinal Toxicity: Common side effects include nausea, vomiting, diarrhea, abdominal pain, and mucositis.
• Hepatic and Renal Impairment: Exercise caution in patients with pre-existing liver or kidney dysfunction, and monitor functions closely.
• Pregnancy and Lactation: Cytarabine is teratogenic and contraindicated during pregnancy. Breastfeeding is not recommended during treatment.
• Infections: Due to immunosuppression, patients are at increased risk of severe infections.
• Handling Precautions: Cytarabine is a hazardous drug; healthcare professionals should wear appropriate personal protective equipment during handling and administration.
• Reporting Side Effects: Patients should immediately report any unusual or severe side effects to their healthcare provider.

Ingredients:

• Active Ingredient: Cytarabine 100 mg/ml
• Excipients: Water for Injection, Hydrochloric Acid (for pH adjustment), Sodium Hydroxide (for pH adjustment), and other pharmaceutical excipients.

Product Details:

• Formulation: Solution for injection
• Strength: 100 mg/ml
• Packaging: 10ml Vial
• Manufacturer: Pfizer (Inferred)